A first-in-human study of, NUC-7738, a 3'dA phosphoramidate, in patients with advanced solid tumors or lymphoma (NuTide 701). Background: The nucleoside analog 5-aza-4’-thio-2’-deoxycytidine (Aza-TdC) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback